Dementia with Diabetes Market Trends By DelveInsight
DelveInsight's "Dementia with Diabetes Market Insights, Epidemiology, and Market Forecast 2030" reports deliver an in-depth understanding of the Dementia with Diabetes Market, historical and forecasted epidemiology, the pipeline insight as well as the Dementia with Diabetes market size and shares analysis in the seven major markets (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) and Japan.
The Dementia with Diabetes market report also covers emerging drugs, current treatment practices, Dementia with Diabetes market shares of the individual therapies, current and forecasted Dementia with Diabetes Market Size segmented by seven major markets.
Dementia with Diabetes Market Key Facts
According to the World Health Organization (WHO), dementia is recognized as a public health priority. In May 2017, the World Health Assembly endorsed the Global action plan on the public health response to dementia 2017–2025. The Plan provides a comprehensive blueprint for action – for policy-makers, international, regional, and national partners.
McMillan et al. conducted a study titled “Impact of pharmacological treatment of diabetes mellitus on dementia risk: systematic review and meta-analysis,” wherein approximately 10% of people with dementia have diabetes mellitus (DM). Dementia in patients with DM occurs at a younger age and is more frequently vascular in etiology compared with individuals without DM. Diabetes was associated with a ∼60% increased risk of all-cause dementia and a 40% risk of nonvascular dementia in both women and men, independent of important confounders. For vascular dementia, the association was stronger, with evidence of a stronger effect in women than in men. Course-modifying treatment and prevention strategies for diabetes-associated cognitive dysfunction, particularly mild cognitive impairment and dementia, remain the highest unmet needs.
Dementia with Diabetes Market Trends
The Dementia with Diabetes market size is expected to change due to the improvement in the diagnosis, incremental healthcare expenditure across the world and anticipated launch of emerging therapies during the forecast period.
The Dementia with Diabetes market analysis section of the report helps to build a detailed comprehension of the historical, current, and forecasted Dementia with Diabetes market trends and growth by analysing the impact of current therapies on the market, unmet needs, drivers, and barriers and demand for better technology. The report gives complete detail of Dementia with Diabetes market size and shares of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, and view of the key opinion leaders.
Dementia with Diabetes Epidemiology Forecast
The Dementia with Diabetes epidemiology section covers insights about historical and current Dementia with Diabetes patient pool and forecasted trends for every seven major countries (i.e., the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan. It helps to recognise the causes of current and forecasted Dementia with Diabetes Epidemiology trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends, along with assumptions undertaken.
There is no cure for Dementia with Diabetes; however, the current treatment option includes non-insulin therapy (Thiazolidinediones, Meglitinides and Dipeptidyl peptidase-4 inhibitors) and insulin therapy. The pipeline for Dementia with Diabetes illustrates a high medical unmet need; therefore, a better treatment option is required in the upcoming Years. Dementia with diabetes market is expected to increase by the major drivers, such as rising prevalent population, technological advancements, and upcoming therapies in the forecast period. Companies worldwide are persistently working toward the development of new treatment therapies, such as vTv Therapeutics LLC and others.
For more details, visit: Dementia with Diabetes Market Trends